Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Colorectal Cancer|Head and Neck Cancer|Lung Cancer|Melanoma (Skin)|Ovarian Cancer|Pancreatic Cancer|Prostate Cancer|Unspecified Adult Solid Tumor, Protocol Specific
Interventions: DRUG: bortezomib|DRUG: paclitaxel
Sponsor: University of Medicine and Dentistry of New Jersey
Collaborators: National Cancer Institute (NCI)